Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Lamm

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2000
Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancerD L Lamm
Texas Medicine|February 1, 1985
Carcinoma of the bladderD L Lamm
Oncology (Williston Park, N.Y.)|October 1, 1995
BCG immunotherapy for transitional-cell carcinoma in situ of the bladderD L Lamm
The Journal of Urology|March 1, 1995
Bladder cancer: improving patient selection and treatmentD L Lamm
The Urologic Clinics of North America|August 1, 1992
Complications of bacillus Calmette-Guérin immunotherapyD L Lamm
The Journal of Urology|March 1, 1997
Re: Assessment of conservative management for stage T10N0M0 transitional cell carcinoma of the bladderD L Lamm
European Urology|November 27, 1999
Preventing progression and improving survival with BCG maintenanceD L Lamm
CA: a Cancer Journal for Clinicians|September 22, 1998
Bladder cancer: twenty years of progress and the challenges that remainD L Lamm
The Journal of Urology|October 1, 1994
RE: Editorial: bladder cancerD L Lamm
Progress in Clinical and Biological Research|January 1, 1988
BCG in carcinoma in situ and superficial bladder tumorsD L Lamm
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2000
Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancerD L Lamm
Texas Medicine|February 1, 1985
Carcinoma of the bladderD L Lamm
Oncology (Williston Park, N.Y.)|October 1, 1995
BCG immunotherapy for transitional-cell carcinoma in situ of the bladderD L Lamm
The Journal of Urology|March 1, 1995
Bladder cancer: improving patient selection and treatmentD L Lamm
The Urologic Clinics of North America|August 1, 1992
Complications of bacillus Calmette-Guérin immunotherapyD L Lamm
The Journal of Urology|March 1, 1997
Re: Assessment of conservative management for stage T10N0M0 transitional cell carcinoma of the bladderD L Lamm
European Urology|November 27, 1999
Preventing progression and improving survival with BCG maintenanceD L Lamm
CA: a Cancer Journal for Clinicians|September 22, 1998
Bladder cancer: twenty years of progress and the challenges that remainD L Lamm
The Journal of Urology|October 1, 1994
RE: Editorial: bladder cancerD L Lamm
Progress in Clinical and Biological Research|January 1, 1988
BCG in carcinoma in situ and superficial bladder tumorsD L Lamm
Pageof 14